Pricing
The US Biotech Drug Pricing Challenge
A series of challenges to the US price tags of important biotech drugs are radiating uncertainty through the biotech industry and investor community. Will the argument for drug value and innovation finally take, or is biotech getting backed into a corner? Tom Norton reports ...Read more
Biotech
California’s Bay Area and the Boston/Cambridge nexus continue to lead bioinnovation in the US
California’s Bay Area and the Boston/Cambridge nexus continue to dominate bioinnovation in the US. Amanda Christini and Ken Kaitin look at the factors contributing to the strategic dominance of these regions
...Read more
Adam Smith Conferences’ Russian Pharmaceutical Forum
Fresh and innovative programme offers plenty of topics and themes to stimulate lively and constructive discussions. HEARover 100 expert speakers (Novartis, AstraZeneca, Pfizer, Teva, Stada, Takeda, Dr.Reddys), EXPERIENCE sessions sharing the best pharmaceutical practices (Generics vs Brands, Biogeneric Producers vs Biological Innovators, Patient Advocacy), LISTEN to special guest addresses (Multichannel Marketing Strategy) and GATHER inspirational ideas from executive debates (Distribution Strategy).
Date: June 17 - 19, 2014
Location: St.Petersburg, Russia
Venue: Corinthia St.Petersburg Hotel
Contact: Lyudmyla Durneva
+44 (0) 207 551 9065
Lyudmyla@adamsmithconferences.com
Website: www.adamsmithconferences.com/as2279PHEX
Marketing Communications
Say What? The Doctor–Patient Conversation
We spend a lot of time focusing on what advertising says to physicians, what reps say to physicians, and what websites and various other channels communicate to patients. But there’s another critical communication channel we can’t ignore, writes Abby Mansfield ...Read more
Patient Communications
Stop Paying Lip Service to Patient Centricity
With the days of blockbuster drugs now mostly gone, every pharma company is trying to squeeze as much as they can from their product portfolio. Conventional methods of marketing no longer yield predictable results, so there’s a need to do something different. That “something different” is focusing on the patient ...Read more
Global
European Clinical Trials: The Die Is Cast
Politicians and health campaigners are celebrating the final agreement of the EU's new clinical trials rules. But the European drug industry is not so euphoric, writes Reflector ...Read more
Leadership
Pharm Exec’s Emerging Pharma Leaders 2014 — Nominate Now
It's time for you to tell us who you think should receive Pharm Exec's 2014 Emerging Pharma Leadership Award. Read more for details of how to nominate a colleague — or yourself. ...Read more |
